| ID | Analyse | Domein | Recipiënt | Uitvoering | LTAT (uren (dagen)) ▲ | Accred. | LOINCeenheid (1) | LOINCeenheid (2) | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 55727 | Nitrazepam (Mogadon) Mogadon | Serum |
1× per week | 217 (9) | – | 3858-8 ng/mL | – nmol/L | › | ||
| 55733 | Triazolam Halcion | Serum |
1× per week | 217 (9) | – | 4069-1 ng/mL | 14926-0 nmol/L | › | ||
| 55736 | Zopiclon | Serum |
1× per week | 217 (9) | – | – ng/mL | – nmol/L | › | ||
| 1272 | Factor V dosage | Citraat |
tenminste 1× per week | 218 (9,1) | – | 3193-0 % | – | › | ||
| 2293 | Famil.hyperlipidemie DNA apoB DNA, Familiale hypercholesterolemie, FH DNA | EDTA |
1× per 3 maanden | 221 (9,2) | – | – | – | › | ||
| 3655 | IgE f55 Sorghum f55 Panicum milliaceum IgE | Serum |
222 (9,2) | – | 6175-4 kU/l | – | › | |||
| 4156 | Brucella canis | Serum |
maandag t/m vrijdag | 226 (9,4) | – | – | – | › | ||
| 4513 | Feline herpesvirus | Serum |
1× per week | 226 (9,4) | – | – | – | › | ||
| 23226 | Huid (1/10) Anti-huid antistoffen, Basale membraan van de huid antistoffen, Keratinocyten antistoffen | Serum |
3× per week | 228 (9,5) | – | 66881-4 | – | › | ||
| 5148 | Insuline kat | Serum |
1× per 2 weken | 228 (9,5) | – | – uU/mL | – | › | ||
| 5096 | P1NP Procollagen type 1 N-terminal Propeptide | Serum |
1× per week | 231 (9,6) | – | 47255-5 µg/L | – | › | ||
| 56278 | Styreen | Heparine (Lithium-heparinebuis) |
1× per week | 235 (9,8) | – | 8243-8 µg/l | – | › | ||
| 4543 | Rickettsia AS | Serum |
1× per week | 237 (9,9) | – | – | – | › | ||
| 5095 | CTX Beta-Crosslaps, C-terminaal telopeptide | EDTA |
maandag t/m vrijdag | 241 (10) | – | 41171-0 µg/L | – | › | ||
| 4816 | Rickettsia conorii IF IgG | Serum |
241 (10) | – | 21492-4 | – | › | |||
| 23208 | Pancreas (1/10)ICA Anti-beta cel antistoffen (1/10), ICA, Antistoffen tegen de eilandjes van Langerhans (1/10), ICA, Antistoffen tegen de eilandjes van Langerhans (1/10), Islet cell | Serum |
tenminste 1× per week | 247 (10,3) | – | 5265-4 | – | › | ||
| 56175 | Aluminium (plasma) Al | Oligo-elementen (spoorelementen) |
2× per week | 248 (10,3) | B | 5574-9 µg/dL | 5574-9 µg/L | › | ||
| 23210 | Gestreepte spier (1/20) Anti-gestreept spierweefsel antistoffen, Dwars gestreepte spierweefsel antistoffen, Skeletspierweefsel antistoffen | Serum |
in batch, zodra er voldoende aanvragen zijn | 248 (10,4) | – | 57744-5 | – | › | ||
| 56182 | Selenium (volbloed) Se | Oligo-elementen (spoorelementen) |
tenminste 2× per week | 250 (10,4) | B | 5722-4 µg/L | 78696-2 µmol/L | › | ||
| 56165 | Mangaan (plasma) Mn | Oligo-elementen (spoorelementen) |
2× per week | 253 (10,6) | B | 5683-8 µg/L | 25467-2 nmol/L | › | ||
| 4752 | Hondeziekte Carré-Distemper antistoffen | Serum |
4× per week | 255 (10,6) | – | – | – | › | ||
| 6003 | Amisulpride | Serum |
256 (10,6) | – | 85384-6 µg/L | – | › | |||
| 56130 | Kwik (volbloed) Hg | Oligo-elementen (spoorelementen) |
tenminste 1× per week | 256 (10,7) | B | 5685-3 µg/l | 25170-2 nmol/L | › | ||
| 56140 | Chroom (plasma) Cr | Oligo-elementen (spoorelementen) |
2× per week | 259 (10,8) | B | 5622-6 µg/l | 25374-0 nmol/L | › | ||
| 56201 | Kobalt (plasma) Co | Oligo-elementen (spoorelementen) |
2× per week | 259 (10,8) | B | 5627-5 µg/L | 25378-1 nmol/L | › | ||
| 5617 | Infliximab | Serum |
1× per week | 260 (10,8) | – | 86896-8 µg/ml | – | › | ||
| 8257 | Trifluoroazijnzuur TFA, Trifluoroazijnzuur | Urine |
261 (10,9) | – | – mg/l | – | › | |||
| 56271 | Tolueen | Heparine (Lithium-heparinebuis) |
1× per week | 264 (11) | – | 9637-0 µg/l | – | › | ||
| 56155 | Molybdeen (volbloed) Mo | Oligo-elementen (spoorelementen) |
1× per week | 265 (11) | B | 5696-0 µg/L | 55555-7 nmol/L | › | ||
| 3990 | IgE w230 nAmba1 Ambrosia | Serum |
267 (11,1) | – | 65782-5 kU/l | – | › | |||
| 8403 | Luchtweg groot hond PCR | eSwab (Wissers varia / Overig) |
267 (11,1) | – | – | – | › | |||
| 24833 | Chlamydia psittaci IgM Ornithosis IgM antistoffen | Serum |
tenminste 1× per week | 268 (11,2) | – | 22181-2 | – | › | ||
| 56190 | Molybdeen (plasma) Mo | Oligo-elementen (spoorelementen) |
2× per week | 269 (11,2) | B | 5698-6 µg/L | 25481-3 nmol/L | › | ||
| 23222 | Bijnier (1/10) | Serum |
in batch, zodra er voldoende aanvragen zijn | 272 (11,3) | – | 57745-2 | – | › | ||
| 4749 | Equine Influenza Virus | Serum |
274 (11,4) | – | – | – | › | |||
| 5094 | Osteocalcine Gla | EDTA |
274 (11,4) | – | 2697-1 ng/mL | – | › | |||
| 3277 | anti-MuSK As Anti-muscle specific kinase antistoffen | Serum |
278 (11,6) | – | 94273-0 | – | › | |||
| 5152 | Vrij T4 (evenwichtsdial.) T4 ED, T4 Evenwichtsdialyse, Vrij Thyroxine ft4 | Serum |
279 (11,6) | – | – ng/dL | – | › | |||
| 4489 | C.perfringens enterotoxin | Faeces |
1× per week | 282 (11,7) | – | – | – | › | ||
| 5921 | Olanzapine Zalasta, Zyprexa | Serum |
1× per week, op donderdag | 283 (11,8) | – | 12389-3 µg/L | – | › | ||
| 5978 | Amikacine Dal Amukin | Serum |
291 (12,1) | – | 3321-7 mg/l | – µmol/L | › | |||
| 4406 | Cryptococcus Neoform. PCR | eSwab (Wissers varia / Overig) |
2× per week | 291 (12,1) | – | – | – | › | ||
| 4540 | Salmonella PCR | Faeces |
291 (12,1) | – | – | – | › | |||
| 3827 | IgE f313 Ansjovis | Serum |
292 (12,2) | – | 7079-7 kU/l | – | › | |||
| 4306 | Ech.multilocularis(ELISA) | Serum |
295 (12,3) | – | – Ratio | – | › | |||
| 8735 | FCoV (F.I.P.) IFT | Punctievocht (Ascites / Pleura / Pericard) |
296 (12,3) | – | – | – | › | |||
| 2642 | Aminozuren kwantitatief | Heparine (Lithium-heparinebuis) |
2× per week | 303 (12,6) | – | 1913-3 | 35083-5 | › | ||
| 57151 | 17-hydroxyprogest. 30min 17-OH progesteron 30min. | Serum |
3× per week | 304 (12,7) | B | 101311-9 ng/dl | 55470-9 nmol/l | › | ||
| 23220 | Acetylcholinereceptor As | Serum |
1× per 1–2 weken | 308 (12,8) | – | 20427-1 nmol/l | – | › | ||
| 2655 | alfa Galactosidase | EDTA |
1× per week | 308 (12,9) | – | 1813-5 µmol/L/h | – | › |
